Turning the spotlight on the oligosaccharide chain of GM1 ganglioside
Open Access
- 23 February 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Glycoconjugate Journal
- Vol. 38 (1), 101-117
- https://doi.org/10.1007/s10719-021-09974-y
Abstract
It is well over a century that glycosphingolipids are matter of interest in different fields of research. The hydrophilic oligosaccharide and the lipid moiety, the ceramide, both or separately have been considered in different moments as the crucial portion of the molecule, responsible for the role played by the glycosphingolipids associated to the plasma-membranes or to any other subcellular fraction. Glycosphingolipids are a family of compounds characterized by thousands of structures differing in both the oligosaccharide and the ceramide moieties, but among them, the nervous system monosialylated glycosphingolipid GM1, belonging to the group of gangliosides, has gained particular attention by a multitude of Scientists. In recent years, a series of studies have been conducted on the functional roles played by the hydrophilic part of GM1, its oligosaccharide, that we have named “OligoGM1”. These studies allowed to shed new light on the mechanisms underlying the properties of GM1 defining the role of the OligoGM1 in determining precise interactions with membrane proteins instrumental for the neuronal functions, leaving to the ceramide the role of correctly positioning the GM1 in the membrane crucial for the oligosaccharide-protein interactions. In this review we aim to report the recent studies on the cascade of events modulated by OligoGM1, as the bioactive portion of GM1, to support neuronal differentiation and trophism together with preclinical studies on its potential to modify the progression of Parkinson’s disease.Keywords
Funding Information
- Mizutani Foundation for Glycoscience
- University of Milano departmental funds PSR2019_CHIRICOZZI
- University of Milano departmental funds deriving by the analytical service
This publication has 106 references indexed in Scilit:
- A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patientsJournal of the Neurological Sciences, 2013
- Regulation of Protein Kinase C function by phosphorylation on conserved and non-conserved sitesCellular Signalling, 2011
- Mice Lacking Major Brain Gangliosides Develop ParkinsonismNeurochemical Research, 2011
- New findings on nuclear gangliosides: overview on metabolism and functionJournal of Neurochemistry, 2011
- Phospholipase C is a key enzyme regulating intracellular calcium and modulating the phosphoinositide balanceProgress in Lipid Research, 2010
- Sodium-calcium exchanger complexed with GM1 ganglioside in nuclear membrane transfers calcium from nucleoplasm to endoplasmic reticulumProceedings of the National Academy of Sciences of the United States of America, 2009
- Genetic engineering of Escherichia coli for the economical production of sialylated oligosaccharidesJournal of Biotechnology, 2008
- Effects of Specific Gangliosides on the In Vitro Proliferation of MPTP‐Susceptible CellsJournal of Neurochemistry, 1993
- The mechanism of protein kinase C activationTrends in Neurosciences, 1989
- A new procedure for the extraction, purification and fractionation of brain gangliosidesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973